n.抗毒素；免疫毒素

The immunotoxin was designed to target cancer cells specifically, minimizing damage to healthy tissue.
免疫毒素被设计用于特异性地针对癌细胞，从而尽量减少对健康组织的损害。
Researchers have developed a new immunotoxin that shows promise in the treatment of leukemia.
研究人员开发了一种新的免疫毒素，在白血病治疗方面展现出前景。
By conjugating the antibody with a toxin, scientists created an immunotoxin capable of destroying targeted pathogens.
通过将抗体与毒素结合，科学家们创造出能够摧毁目标病原体的免疫毒素。
In preclinical studies, the immunotoxin demonstrated high potency and specificity against glioma cells.
在临床前研究中，这种免疫毒素显示出了对胶质瘤细胞的高度效力和特异性。
The use of immunotoxins has been explored as a potential therapy for refractory and relapsed Hodgkin's lymphoma.
已经探索了使用免疫毒素作为难治性和复发性霍奇金淋巴瘤的潜在疗法。
An immunotoxin targeting B-cell surface antigens is currently under investigation in phase II clinical trials.
目前正在II期临床试验中调查一种靶向B细胞表面抗原的免疫毒素。
The success of the immunotoxin treatment relies heavily on its ability to selectively bind to tumor-associated antigens.
免疫毒素治疗的成功很大程度上依赖于其选择性地结合肿瘤相关抗原的能力。
Researchers engineered an immunotoxin by fusing a monoclonal antibody with a potent bacterial toxin fragment.
研究人员通过融合单克隆抗体和一种强力细菌毒素片段，制造出了一种工程化免疫毒素。
Due to its high cytotoxicity, the dosage and administration of immunotoxin must be carefully controlled in clinical applications.
由于其高细胞毒性，免疫毒素在临床应用中的剂量和给药方式必须谨慎控制。
One of the challenges in developing immunotoxins is ensuring they do not provoke an immune response that could neutralize their effectiveness.
开发免疫毒素面临的挑战之一是确保它们不会引发中和其效力的免疫反应。